Earnings Feed
Start Free
HOME BANCORP, INC.·4

Apr 28, 7:00 PM ET

Zollinger John J. IV 4

4 · HOME BANCORP, INC. · Filed Apr 28, 2026

Research Summary

AI-generated summary of this filing

Updated

Home Bancorp SEVP John J. Zollinger Exercises Options, Sells Shares

What Happened
John J. Zollinger IV, Senior EVP and Chief Banking Officer of Home Bancorp (HBCP), exercised 660 stock options on April 28, 2026 at an exercise price of $28.00 per share (total cost $18,480) and disposed of 311 shares in an open-market sale at $63.12 per share for total proceeds of $19,630. The filing also shows a derivative disposition of 660 shares related to the exercise (reported at $0), consistent with conversion/exercise activity.

Key Details

  • Transaction date: 2026-04-28.
  • Option exercise: 660 shares exercised at $28.00 — $18,480 cash paid.
  • Open-market sale: 311 shares sold at $63.12 — $19,630 proceeds.
  • Derivative disposition: 660 shares reported as disposed at $0 (related to the exercise).
  • Footnotes of note: F6 indicates shares sold to cover exercise price; F12 shows 660 options were available to exercise as of the filing.
  • Shares owned after transaction: Not specified in this filing.
  • Filing timeliness: Reported with the same transaction date; no late filing indicated.

Context
This was an option exercise combined with a partial disposition; the sale of shares to cover exercise/tax obligations (per footnote F6) is common in cashless or sell-to-cover exercises. Such routine insider exercises and partial sales do not, by themselves, indicate the insider’s long-term view of the stock.

Insider Transaction Report

Form 4
Period: 2026-04-28
HOME BANCORP, INC.HBCP
Zollinger John J. IV
SEVP, Chief Banking Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1][F2][F3][F4][F5]
    2026-04-28$28.00/sh+660$18,480→ 7,752 total
  • Sale

    Common Stock

    [F6][F1][F2][F3][F4][F5]
    2026-04-28$63.12/sh−311$19,630→ 7,441 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    [F12]
    2026-04-28−660→ 0 total
    Exercise: $28.00Exp: 2026-05-23→ Common Stock (660 underlying)
Holdings

  • Common Stock

    (indirect: By 401(k))
    1,417.389

  • Common Stock

    (indirect: ESOP)
    6,860.416

  • Employee Stock Option (Right to Buy)

    [F7]
    Exercise: $35.26Exp: 2027-05-12→ Common Stock (750 underlying)
    750

  • Employee Stock Option (Right to Buy)

    [F8]
    Exercise: $45.12Exp: 2028-05-23→ Common Stock (740 underlying)
    740

  • Employee Stock Option (Right to Buy)

    [F9]
    Exercise: $35.85Exp: 2029-05-23→ Common Stock (850 underlying)
    850

  • Employee Stock Option (Right to Buy)

    [F10]
    Exercise: $21.99Exp: 2030-03-12→ Common Stock (800 underlying)
    800

  • Employee Stock Option (Right to Buy)

    [F11]
    Exercise: $36.77Exp: 2031-05-12→ Common Stock (1,000 underlying)
    1,000
Footnotes (12)
  • [F1]Includes the grant of 1400 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2024, and that may be settled only in shares of the Issuer's common stock. As of July 15, 2024, 1,120 restricted stock units remain unvested.
  • [F10]The options vest and become exercisable in five equal installments beginning March 12, 2021.
  • [F11]The options vest and become exercisable in five equal installments beginning May 12, 2022.
  • [F12]The options vest and become exercisable in five equal installments beginning May 23, 2017. As of the date of this filing 660 options were available to exercise.
  • [F2]Includes the grant of 1590 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2026, and that may be settled only in shares of the Issuer's common stock.
  • [F3]Includes the grant of 1600 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2025, and that may be settled only in shares of the Issuer's common stock.
  • [F4]Includes the grant of 425 restricted stock units pursuant to the Issuer's 2014 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2022, and that may be settled only in shares of the Issuer's common stock. As of July 15, 2024, 170 restricted stock units remain unvested.
  • [F5]Includes the grant of 975 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2023, and that may be settled only in shares of the Issuer's common stock. As of July 15, 2024, 585 restricted stock units remain unvested.
  • [F6]Shares sold to cover exercise price
  • [F7]The options vest and become exercisable in five equal installments beginning May 12, 2018.
  • [F8]The options vest and become exercisable in five equal installments beginning May 23, 2019.
  • [F9]The options vest and become exercisable in five equal installments beginning May 23, 2020.
Signature
/s/ John J. Zollinger, IV|2026-04-28

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT